|
|
Volumn 3, Issue 3, 1998, Pages 105-111
|
|
The elderly, medicines and robust evidence from randomised control trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
BROMOCRIPTINE;
BRONCHODILATING AGENT;
CABERGOLINE;
CALCIUM CHANNEL BLOCKING AGENT;
CERIVASTATIN;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
HEPARIN;
LEVODOPA;
METRIFONATE;
MEVINOLIN;
MUSCARINIC M1 RECEPTOR ANTAGONIST;
NICOTINIC ACID;
OXYGEN;
PHOSPHODIESTERASE INHIBITOR;
PHYSOSTIGMINE;
PROPENTOFYLLINE;
SABELUZOLE;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
ASSISTED VENTILATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DIET;
DRUG MONITORING;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HUMAN;
HYPERCHOLESTEROLEMIA;
MEDICAL DECISION MAKING;
META ANALYSIS;
PALLIATIVE THERAPY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 0031709589
PISSN: 13615874
EISSN: None
Source Type: Journal
DOI: 10.1108/eb020883 Document Type: Article |
|
Times cited : (4)
|
|
References (34)
|
